AIMS: To determine the reliability and validity of the Severity of Dependence Scale (SDS) for detecting cannabis dependence in a large sample of in-patients with a schizophrenia spectrum disorder. DESIGN: Cross-sectional study. PARTICIPANTS: Participants were 153 in-patients with a schizophrenia spectrum disorder in Brisbane, Australia. MEASUREMENTS: Participants were administered the SDS for cannabis dependence in the past 12 months. The presence of Diagnostic and Statistical Manual Version-IV (DSM-IV) cannabis dependence in the previous 12 months was assessed using the Comprehensive International Diagnostic Interview (CIDI). FINDINGS: The SDS had high levels of internal consistency and strong construct and concurrent validity. Individuals with a score of >or = 2 on the SDS were nearly 30 times more likely to have DSM-IV cannabis dependence. The SDS was the strongest predictor of DSM-IV cannabis dependence after controlling for other predictor variables. CONCLUSIONS: The SDS is a brief, valid and reliable screen for cannabis dependence among people with psychosis.
AIMS: To determine the reliability and validity of the Severity of Dependence Scale (SDS) for detecting cannabis dependence in a large sample of in-patients with a schizophrenia spectrum disorder. DESIGN: Cross-sectional study. PARTICIPANTS: Participants were 153 in-patients with a schizophrenia spectrum disorder in Brisbane, Australia. MEASUREMENTS: Participants were administered the SDS for cannabis dependence in the past 12 months. The presence of Diagnostic and Statistical Manual Version-IV (DSM-IV) cannabis dependence in the previous 12 months was assessed using the Comprehensive International Diagnostic Interview (CIDI). FINDINGS: The SDS had high levels of internal consistency and strong construct and concurrent validity. Individuals with a score of >or = 2 on the SDS were nearly 30 times more likely to have DSM-IV cannabis dependence. The SDS was the strongest predictor of DSM-IV cannabis dependence after controlling for other predictor variables. CONCLUSIONS: The SDS is a brief, valid and reliable screen for cannabis dependence among people with psychosis.
Authors: Peggy van der Pol; Nienke Liebregts; Ron de Graaf; Dirk J Korf; Wim van den Brink; Margriet van Laar Journal: Int J Methods Psychiatr Res Date: 2013-05-14 Impact factor: 4.035
Authors: Jamey J Lister; Guijin Lee; Jennifer D Ellis; Emily Pasman; Elizabeth Agius; Stella M Resko Journal: Front Psychiatry Date: 2022-05-02 Impact factor: 5.435
Authors: Johanna Koskinen; Johanna Löhönen; Hannu Koponen; Matti Isohanni; Jouko Miettunen Journal: Schizophr Bull Date: 2009-04-22 Impact factor: 9.306
Authors: Francisca López-Torrecillas; Eva María López-Quirantes; Antonio Maldonado; Natalia Albein-Urios; Mª Del Mar Rueda; Antonio Verdejo-Garcia Journal: PLoS One Date: 2017-12-04 Impact factor: 3.240